Press Release: BatuBiologics : Vice Chairman of Immunology at The Scripps Research Institute to Assist with ValloVax Clinical Development

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax , announced today the appointment of Argyrios Theofilopoulos, MD of The Scripps Research Institute to its scientific advisory board. In this role, Dr. Theofilopoulos will assist in the development of the ValloVax program with a focus on optimizing the clinical protocol to maximize patient benefit. "It is a privilege to work alongside su